LianBio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	34	178	661	-
Market Cap Growth	-26.32%	-73.10%	-	-
Enterprise Value	-215	-120	282	-252
PE Ratio	-	-1.61	-3.36	-
PB Ratio	0.17	0.68	1.87	-
P/FCF Ratio	-1.90	-1.76	-4.01	-
P/OCF Ratio	-1.91	-1.79	-4.03	-
EV/EBITDA Ratio	1.04	1.10	-1.44	1.87
EV/EBIT Ratio	1.03	1.09	-1.44	1.87
EV/FCF Ratio	1.07	1.19	-1.71	2.55
Debt / Equity Ratio	0.01	0.02	0.01	-0.01
Debt / EBITDA Ratio	-0.03	-0.04	-0.02	-0.01
Debt / FCF Ratio	-0.03	-0.04	-0.03	-0.02
Quick Ratio	9.88	12.88	25.79	44.07
Current Ratio	10.06	13.25	26.48	44.45
Interest Coverage	-	-	-	-27.76
Return on Equity (ROE)	-38.10%	-38.20%	-177.90%	187.80%
Return on Assets (ROA)	-30.20%	-30.30%	-55.60%	-86.40%
Return on Capital (ROIC)	-51.93%	-47.44%	-54.57%	102.98%
Earnings Yield	-253.39%	-62.07%	-29.72%	-
FCF Yield	-241.90%	-56.85%	-24.96%	-
Buyback Yield / Dilution	1.09%	-213.78%	-185.40%	-
Total Shareholder Return	1.09%	-213.78%	-185.40%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).